103 related articles for article (PubMed ID: 7962467)
1. Effects of D-ring substituents on antiprogestational (antagonist) and progestational (agonist) activity of 11 beta-aryl steroids.
Cook CE; Lee YW; Wani MC; Fail PA; Petrow V
Hum Reprod; 1994 Jun; 9 Suppl 1():32-9. PubMed ID: 7962467
[TBL] [Abstract][Full Text] [Related]
2. Reversal of activity profile in analogs of the antiprogestin RU 486: effect of a 16 alpha-substituent on progestational (agonist) activity.
Cook CE; Wani MC; Lee YW; Fail PA; Petrow V
Life Sci; 1993; 52(2):155-62. PubMed ID: 8355555
[TBL] [Abstract][Full Text] [Related]
3. 11 beta-substituted 13 beta-ethyl gonane derivatives exhibit reversal of antiprogestational activity.
Rao PN; Cessac JW; Blye RP; Kim HK
Steroids; 1998 Jan; 63(1):50-7. PubMed ID: 9437795
[TBL] [Abstract][Full Text] [Related]
4. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
Horwitz KB
Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestins.
Nickisch K; Elger W; Cessac J; Kesavaram N; Das B; Garfield R; Shi SQ; Amelkina O; Meister R
Steroids; 2013 Feb; 78(2):255-67. PubMed ID: 23178161
[TBL] [Abstract][Full Text] [Related]
6. In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone.
Attardi BJ; Burgenson J; Hild SA; Reel JR
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):277-88. PubMed ID: 15120421
[TBL] [Abstract][Full Text] [Related]
7. RU486 is not an antiprogestin in the hamster.
Gray GO; Leavitt WW
J Steroid Biochem; 1987 Nov; 28(5):493-7. PubMed ID: 3682817
[TBL] [Abstract][Full Text] [Related]
8. New 11 beta-aryl-substituted steroids exhibit both progestational and antiprogestational activity.
Rao PN; Wang Z; Cessac JW; Rosenberg RS; Jenkins DJ; Diamandis EP
Steroids; 1998 Oct; 63(10):523-30. PubMed ID: 9800283
[TBL] [Abstract][Full Text] [Related]
9. Screening of anti-progestagens by receptor studies and bioassays.
Kloosterboer HJ; Deckers GH; van der Heuvel MJ; Loozen HJ
J Steroid Biochem; 1988 Oct; 31(4B):567-71. PubMed ID: 3199806
[TBL] [Abstract][Full Text] [Related]
10. New-D-homoandrost-4,6-diene derivatives as potent progesterone receptor antagonist.
Cabeza M; García-Lorenzana M; Garcés M; Heuze I; Teran N; Bratoeff E
Steroids; 2010 Jan; 75(1):101-8. PubMed ID: 19913568
[TBL] [Abstract][Full Text] [Related]
11. A single amino acid that determines the sensitivity of progesterone receptors to RU486.
Benhamou B; Garcia T; Lerouge T; Vergezac A; Gofflo D; Bigogne C; Chambon P; Gronemeyer H
Science; 1992 Jan; 255(5041):206-9. PubMed ID: 1372753
[TBL] [Abstract][Full Text] [Related]
12. Effect of a 17alpha-(3-hydroxypropyl)-17beta-acetyl substituent pattern on the glucocorticoid and progestin receptor binding of 11beta-arylestra-4,9-dien-3-ones.
Cook CE; Raje P; Lee DY; Kepler JA
Org Lett; 2001 Apr; 3(7):1013-6. PubMed ID: 11277783
[TBL] [Abstract][Full Text] [Related]
13. History and perspectives of antiprogestins from the chemist's point of view.
Teutsch G; Philibert D
Hum Reprod; 1994 Jun; 9 Suppl 1():12-31. PubMed ID: 7962457
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in structure of progestins and their binding to progesterone receptors.
Cabeza M; Heuze Y; Sánchez A; Garrido M; Bratoeff E
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):152-9. PubMed ID: 24666307
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological testing of 4'-(dimethylamino)-17 beta-hydroxy-17 alpha-(1-propynyl)benzo[12,12a]-11 alpha,18-cyclo-12a,12b-dihomo-13 alpha-estr-4-en-3-one: an interesting RU 38 486 analog.
Ottow E; Beier S; Elger W; Fritzemeier KH; Neef G; Wiechert R
Steroids; 1994 Mar; 59(3):185-9. PubMed ID: 8048150
[TBL] [Abstract][Full Text] [Related]
16. Binding of RU486 and deacylcortivazol to the glucocorticoid receptor is insensitive to sulfhydryl-modifying agents.
Burollaud T; Danzé PM; Tbarka N; Formstecher P; Dautrevaux M
J Steroid Biochem Mol Biol; 1993 Mar; 44(3):217-25. PubMed ID: 8461255
[TBL] [Abstract][Full Text] [Related]
17. Switching agonistic, antagonistic, and mixed transcriptional responses to 11 beta-substituted progestins by mutation of the progesterone receptor.
Garcia T; Benhamou B; Gofflo D; Vergezac A; Philibert D; Chambon P; Gronemeyer H
Mol Endocrinol; 1992 Dec; 6(12):2071-8. PubMed ID: 1337143
[TBL] [Abstract][Full Text] [Related]
18. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antihormonal properties of novel 11β-benzoxazole-substituted steroids.
Jin C; Fix SE; Kepler JA; Cook CE
Bioorg Med Chem Lett; 2012 Feb; 22(4):1705-8. PubMed ID: 22260770
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
